Customer Center
Login | Register

Clinical

Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.

Read More

 

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.

Read More

 

Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.

Learn More

 

Luminex® Blog

ARIES Pediatric Study Demonstrates Less Invasive Solution for Enterovirus Testing

Better diagnostic tools could have a major impact in patient care

At this year’s Clinical Virology Symposium (CVS), Xiaotian Zheng’s spoke about developing and evaluating a laboratory developed test (LDT) on the ARIES® System for detecting enteroviruses in blood samples from children. The enterovirus study began with a plea from his hospital’s emergency department to decrease the number of painful, invasive spinal taps performed on children…”

Continue Reading…

ARIES® System &
SYNCT™ Software



Experience an ARIES® System & SYNCT™ Software, enabling cassettes to be associated with orders from anywhere in the lab network.

Watch more videos >

Luminex on Twitter


Introducing #TheFacesofLuminex, a blog series focusing on our amazing employees. Up first, @kbmTexasCPA: https://t.co/GDG7eBqYcY
h J R
#Zika virus can persist for months in newborns, case study suggests: https://t.co/J6JIbNaAu7 https://t.co/R7cYugTNsh
h J R
RT @CDCgov: New CDC #VitalSigns report: Healthcare providers can help prevent infections & illnesses that can lead to sepsis. https://t.co/
h J R

Latest News

August 8
Luminex Corporation Receives FDA Emergency Use Authorization for Zika Virus Molecular Detection Assay

August 3
Luminex Corporation Receives FDA Clearance for New Molecular Test for Identification and Differentiation of Influenza A/B and Respiratory Syncytial Virus

July 28
Luminex Corporation Reports Second Quarter 2016 Results

July 20
Luminex Corporation Second Quarter Earnings Release Scheduled for July 28; Revision to Conference Call Date/Time

July 8
Luminex Corporation Second Quarter Earnings Release Scheduled for July 28, 2016

July 6
Luminex Corporation Receives FDA Clearance and CE-IVD Mark for the ARIES M1 System

Events

34th Annual Conference on Pediatric Infectious Diseases
July 31-August 5
Vail, CO

AACC Annual Meeting & Clinical Lab Expo
August 2-4
Philadelphia, PA

SWACM Annual Meeting
September 7-10
Ft. Worth, TX

IDWeek
October 26-30
New Orleans, LA

AMP Annual Meeting
November 10-12
Charlotte, NC